Eli Lilly Licenses ADDF’s SpeechDx Dataset for Alzheimer’s Research
· unite.ai · popularity 19/100 · 0 similar stories today · Brain & Neuroscience (Discovery & Research)
Read the original at unite.ai →
Summary
The Alzheimer's Drug Discovery Foundation (ADDF) announced on October 28, 2026 that Eli Lilly and Company has licensed SpeechDx, a longitudinal speech-and-biomarker dataset built by the foundation's Diagnostics Accelerator, and will use the resource to study whether speech can serve as a tool for Alzheimer's research. Lilly is the third organization to license the dataset, joining Siemens Healthineers and Callyope. The foundation characterizes SpeechDx as the largest harmonized longitudinal…
Found in: Unite.AI. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.